Literature DB >> 1583928

Patient-based health status measures in outpatient dialysis. Early experiences in developing an outcomes assessment program.

P S Kurtin1, A R Davies, K B Meyer, J M DeGiacomo, M E Kantz.   

Abstract

This paper describes the initial development of a patient-based outcomes assessment program in an outpatient dialysis unit. This project presented four logistical and practical issues that are discussed in this paper: patient acceptance of quarterly administrations of a generic health status survey (the SF-36); timing of administration during dialysis session; respondent burden; and staff burden. Also discussed are three issues related to the clinical use of these assessments: medical record status of SF-36 data; use in clinical decisionmaking; and clinicians' responses to aggregate data from patient-based health status assessments. The investigation reported presents strong evidence of patient acceptance of the SF-36. Data collection problems reflected the nature of a busy dialysis unit, and most have been corrected. Considering functional status, the role functioning of dialysis patients is most adversely affected; among well-being measures, patients are most compromised by pain and lack of energy. Clinicians' reviews of these results point to the need for normative data, information about severity of primary and comorbid diseases, and knowledge of relationships between SF-36 scores and physiologic parameters to make clinical use of generic health outcome assessments.

Entities:  

Mesh:

Year:  1992        PMID: 1583928     DOI: 10.1097/00005650-199205001-00012

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  31 in total

Review 1.  A comparative review of generic quality-of-life instruments.

Authors:  S J Coons; S Rao; D L Keininger; R D Hays
Journal:  Pharmacoeconomics       Date:  2000-01       Impact factor: 4.981

2.  The SF36 as an outcome measure of services for end stage renal failure.

Authors:  J P Wight; L Edwards; J Brazier; S Walters; J N Payne; C B Brown
Journal:  Qual Health Care       Date:  1998-12

3.  Estimation and comparison of derived preference scores from the SF-36 in lung transplant patients.

Authors:  Francis S Lobo; Cynthia R Gross; Barbara J Matthees
Journal:  Qual Life Res       Date:  2004-03       Impact factor: 4.147

4.  Multivariate analysis of health status scores: chronic airway disorders and the MOS SF-36.

Authors:  E R Cox; C M Kozma; C E Reeder
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 5.  A review of the progress towards developing health-related quality-of-life instruments for international clinical studies and outcomes research.

Authors:  R T Anderson; N K Aaronson; M Bullinger; W L McBee
Journal:  Pharmacoeconomics       Date:  1996-10       Impact factor: 4.981

Review 6.  Measuring the health status burden in hemodialysis patients using the SF-36® health survey.

Authors:  Aaron S Yarlas; Michelle K White; Min Yang; Renee N Saris-Baglama; Peter Galthen Bech; Torsten Christensen
Journal:  Qual Life Res       Date:  2010-10-23       Impact factor: 4.147

7.  International Quality of Life Assessment (IQOLA) Project.

Authors:  N K Aaronson; C Acquadro; J Alonso; G Apolone; D Bucquet; M Bullinger; K Bungay; S Fukuhara; B Gandek; S Keller
Journal:  Qual Life Res       Date:  1992-10       Impact factor: 4.147

8.  The determinants of CABG patients' outcomes.

Authors:  I Sahin; T T Wan; B Sahin
Journal:  Health Care Manag Sci       Date:  1999-12

9.  Health outcomes by self-report: validity of the SF-36 among Australian hospital patients.

Authors:  B Shadbolt; J McCallum; M Singh
Journal:  Qual Life Res       Date:  1997-05       Impact factor: 4.147

10.  Design and rationale of health-related quality of life and patient-reported outcomes assessment in the Frequent Hemodialysis Network trials.

Authors:  Manisha Jhamb; Manjula K Tamura; Jennifer Gassman; Amit X Garg; Robert M Lindsay; Rita S Suri; George Ting; Fredric O Finkelstein; Scott Beach; Paul L Kimmel; Mark Unruh
Journal:  Blood Purif       Date:  2011-01-10       Impact factor: 2.614

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.